Pharma scientists announced for AAPS executive council and section leadership positions.
The American Association of Pharmaceutical Scientists (AAPS) announced its executive council and section leadership in late August 2015. Binodh S. DeSilva, Bristol-Myers Squibb Company, was elected to serve as president-elect; she will begin a three-year term on the AAPS Executive Council (as president-elect, president, and immediate past president) in October 2015 at the 2015 AAPS Annual Meeting and Exposition in Orlando, FL.
William E. Weiser, Patheon, Inc., was elected as AAPS treasurer and Joseph W. Polli, GlaxoSmithKline, was elected as AAPS member-at-large. They join members-at-large Christopher R. McCurdy, Andrew M. Vick, Robert L. Chapman, and Stacey J. Tannenbaum, 2015 President Gregory E. Amidon, and Immediate Past President Alice E. Till, as members on the 2015 AAPS Executive Council.
AAPS also announced leaders for the organization’s nine sections guided by scientific disciplines:
Source: AAPS
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.